On September 25, the State Council Information Office held a briefing to introduce the progress of the work on the new coronavirus vaccine and answer questions from reporters.
At the meeting, Zheng Zhongwei, the leader of the Vaccine R&D Team of the Scientific Research Group and Director of the National Health and Health Commission's Medical and Health Technology Development Center, said that according to current estimates, by the end of this year, the annual production capacity of new crown vaccine is expected to reach 610 million doses. , The annual production capacity can reach more than 1 billion doses.
According to Zheng Zhongwei, taking inactivated vaccines as an example, its production requirements are very high and require high-level production workshops. Therefore, the National Health Commission and relevant government departments have formulated standards for high-level production workshops and organized relevant experts. , The institution shall check and accept the advanced biological workshops built by the enterprise.
In addition to the new crown inactivated vaccine, there are also vaccines such as adenovirus vectors and recombinant protein vaccines. Zheng Zhongwei said that the construction of vaccine production capacity of various technical routes is also advancing simultaneously.
According to current estimates, by the end of this year, the annual production capacity of the new crown vaccine is expected to reach 610 million doses. By next year, the annual production capacity can reach more than 1 billion doses.